TitleFrazier, Alan oral history
|Frazier, Alan, Interviewee|
|Kolker, Carole, Interviewer|
PublisherNational Venture Capital Association (NVCA)
DescriptionAlan Frazier is the managing partner of Frazier Healthcare Ventures, a pioneer in healthcare ventures, which he founded in 1991. He is active in evaluating biopharmaceutical and growth equity investments, and he has been integrally involved in growing several successful early-stage life science companies into national prominence ̶ such as Immunex, Affymax and Affymetrix; has secured premiere deal flow through early-stage investments ̶ such as Tularik and CV Therapeutic; and has developed successful growth equity companies such as Trident USA Health Services.
Prior to forming Frazier Healthcare Ventures, Alan was the executive vice president and chief financial officer of Immunex Corporation. Later, he served as the senior financial advisor and chief financial officer of Affymax and worked on the spinout of Affymetrix. Prior to Immunex, Alan was head of the Emerging Business Practice and co-head of the Technology Practice for the Seattle office of Arthur Young Company (now, Ernst & Young). Alan holds a B.A. in Economics from the University of Washington.
Currently, Alan serves on the boards of Alexza Pharmaceuticals, Ascension Orthopedics, Cadence Pharmaceuticals, Calypso Medical Technologies, Portola Pharmaceuticals, and TridentUSA Health Services.
Alan is active in his community, serving on the UW Medicine Board and UW Medicine Strategic Initiatives Committee, both affiliated with the University of Washington School of Medicine. He also serves on the Boards of the Washington Biotechnology and Biomedical Association, the Western Washington University Foundation, and Amara Parenting, an adoption and foster care organization. Alan’s drive and passion come from his “love to create” and his “love to build.”
Collection TitleNVCA Oral History Collection
CreditGift of National Venture Capital Association
|102740514||Frazier, Alan oral history|